LEO Pharma A/S

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Committed

SBTI ID

40006154

Informations générales

Localisation

Denmark

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

24/10/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

LEO Pharma commits to reduce absolute scope 1 and 2 GHG emissions 53% by 2030 from a 2019 base year. LEO Pharma also commits that 75% of its suppliers by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution will have science-based targets by 2026

Net-Zero

Statut

Committed
Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

52990077KVK7QCK2NG31

Source : Science Based Targets initiative | Données publiques